Company Filing History:
1 out of 56 
1 out of 896 
Years Active: 2021
Title: Etsuko Miyagi: Innovator in Ovarian Cancer Detection
Introduction
Etsuko Miyagi is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the detection of ovarian clear cell adenocarcinoma. Her innovative work aims to improve the sensitivity and specificity of cancer detection methods.
Latest Patents
Etsuko Miyagi holds a patent for a method and reagent for detecting ovarian clear cell adenocarcinoma. This invention provides a novel approach to identifying this highly malignant form of cancer among various ovarian tumors. The patent introduces NT-TFPI2, a new detection marker that enhances the accuracy of diagnosis. The detection process involves measuring the amount of NT-TFPI2 or the total amount of NT-TFPI2 and intact TFPI2. The reagent developed for this purpose contains an antibody that specifically recognizes NT-TFPI2 and intact TFPI2. Etsuko Miyagi's patent is a significant advancement in cancer diagnostics, with 1 patent to her name.
Career Highlights
Throughout her career, Etsuko Miyagi has worked with esteemed institutions, including the Public University Corporation Yokohama City University and Tosoh Corporation. Her experience in these organizations has contributed to her expertise in medical research and innovation.
Collaborations
Etsuko has collaborated with notable colleagues such as Noriaki Arakawa and Hisashi Hirano. These partnerships have further enriched her research and development efforts in the field of cancer detection.
Conclusion
Etsuko Miyagi's contributions to the detection of ovarian clear cell adenocarcinoma exemplify her dedication to advancing medical technology. Her innovative methods and collaborations highlight the importance of research in improving cancer diagnostics.